Frank Mccormick - Feb 21, 2023 Form 3 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/Brian Stephenson, as attorney-in-fact
Stock symbol
BBIO
Transactions as of
Feb 21, 2023
Transactions value $
$0
Form type
3
Date filed
2/28/2023, 08:52 PM
Next filing
Dec 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BBIO Common Stock 1.2M Feb 21, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BBIO Stock Option (right to buy) Feb 21, 2023 Common Stock 265K $17.00 Direct F1
holding BBIO Stock Option (right to buy) Feb 21, 2023 Common Stock 10.5K $1.05 Direct
holding BBIO Stock Option (right to buy) Feb 21, 2023 Common Stock 18.6K $40.03 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 237,810 shares have vested to date. The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 26, 2019, subject to the Reporting Person's continued service to the Issuer through each such date.

Remarks:

Exhibit 24 - Power of Attorney